Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and Romiplostim
Condition(s):Immune Thrombocytopenic PurpuraLast Updated:June 25, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Immune Thrombocytopenic PurpuraLast Updated:June 25, 2012Completed
Condition(s):Severe Aplastic Anemia (SAA)Last Updated:September 29, 2023Withdrawn
Condition(s):Bone Marrow Failure Disorders; Aplastic Anemia; Thrombocytopenia; Refractory Cytopenia of Childhood; Myelodysplastic Syndrome(MDS)Last Updated:June 22, 2023Active, not recruiting
Condition(s):Aplastic AnemiaLast Updated:May 26, 2022Completed
Condition(s):Immune Thrombocytopenic PurpuraLast Updated:December 22, 2015Completed
Condition(s):Idiopathic Thrombocytopenic Purpura; Thrombocytopenia; Thrombocytopenic PurpuraLast Updated:November 14, 2022Completed
Condition(s):Idiopathic Thrombocytopenic PurpuraLast Updated:March 6, 2024Completed
Condition(s):Idiopathic Thrombocytopenic Purpura; Thrombocytopenia; Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP); Thrombocytopenic PurpuraLast Updated:November 8, 2022Completed
Condition(s):Idiopathic Thrombocytopenic PurpuraLast Updated:January 10, 2020Completed
Condition(s):Myelodysplastic SyndromesLast Updated:August 16, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.